Scinai Immunotherapeutics secures $4.0 million through a private placement and warrant inducement. This funding will support their ongoing development efforts.
Amount Raised
$4 Million
Round Type
Post-IPO Equity
JerusalemManufacturingBiotechnologyPharmaceuticalBiopharmaDescription
Scinai Immunotherapeutics has announced a financing round totaling $4.0 million. The funding comes through a private placement alongside warrant inducement. The capital is aimed at supporting the company's therapeutic development initiatives. This financing represents a significant boost to their operational capabilities.
Who else raised in Pharmaceutical and Biopharma around the same time
Companies in the same sectors as Scinai Immunotherapeutics Ltd that raised within 45 days of this round, from Fundz verified event records.
- ABVC BioPharma raised $3.4M (Convertible Note) on November 2, 2026.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
- Telomir Pharmaceuticals raised $5.6M (Post-IPO Equity) on October 6, 2026.
Who to call at Scinai Immunotherapeutics Ltd, and when
A new round usually means Scinai Immunotherapeutics Ltd is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Scinai Immunotherapeutics Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Scinai Immunotherapeutics Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Scinai Immunotherapeutics Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Scinai Immunotherapeutics Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Scinai Immunotherapeutics Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.